Rosuvastatin Calcium Tablet 10mg
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Alpha Pharmaceutical Co., Ltd.
MFDS item code 201903275 · Approved 2019.05.21
This product's status changed to Expired on 2024.05.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct when diet and exercise are insufficient to control primary hypercholesterolemia and mixed hyperlipidemia. It is also beneficial in conjunction with diet or other treatments for patients with homozygous familial hypercholesterolemia. It lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It can be used as an adjunct to diet in pediatric patients aged 10 to 17 years with certain familial hypercholesterolemia and is effective in patients with dysbetalipoproteinemia. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and related revascularization procedures in middle-aged individuals at high risk for cardiovascular diseases. In summary, this medication is used for various hypercholesterolemia and reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients who are allergic to any of the components of this medication, those with severely impaired liver function, patients with muscle disorders, patients with severely impaired kidney function, women who are pregnant or breastfeeding, and patients taking certain medications should not take this medication. It is important to periodically check liver function and muscle condition when taking this medication. Patients who consume large amounts of alcohol or have a history of liver disease should be particularly cautious, and any other conditions like hypothyroidism or nephrotic syndrome should be treated beforehand. If muscle pain, weakness, fatigue, or fever occurs, patients should immediately inform their doctor, and if muscle enzyme levels rise significantly, the medication should be discontinued. Additionally, patients at high risk for severe muscle weakness or rhabdomyolysis should use this medication with caution. This medication may interact with other drugs, so if other medications are being taken, one should consult their doctor or pharmacist. Particularly, when taken with certain antivirals, immunosuppressants, antifungals, antibiotics, and fibrate drugs, the risk of muscle damage may increase. Women who might become pregnant should ensure proper contraception, and this medication should not be taken during pregnancy. It is not recommended during breastfeeding either. In case of overdose, there is no specific antidote, so one should visit a medical institution immediately for appropriate treatment. This medication may cause symptoms like dizziness, so caution is advised when driving or operating machinery. Lastly, if any abnormal symptoms such as liver function anomalies, skin rashes, or severe muscle pain occur while taking this medication, they should inform medical personnel right away, and it is important to continue treatment safely through regular check-ups.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced lichenoid skin eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue, joint pain, acute renal failure, oliguria, increased serum creatinine.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. The storage temperature should be maintained between 1 degrees Celsius and 30 degrees Celsius at room temperature.
Pink round film-coated tablet
28 tablets (14 tablets/PTP X 2) - 14 tablets/PTP, 28 tablets (14 tablets/PTP X 2) - 2 PTP/box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Alpha Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.